Cargando…

Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy

BACKGROUND: Interstitial rotating shield brachytherapy (I-RSBT) is a recently developed method for treatment of prostate cancer. In the present study TG-43 dosimetric parameters of a (153)Gd source were obtained for use in I-RSBT. MATERIALS AND METHODS: A (153)Gd source located inside a needle inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghorbani, Mahdi, Khajetash, Benyamin, Ghatei, Najmeh, Mehrpouyan, Mohammad, Meigooni, Ali S., Shahraini, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330175/
https://www.ncbi.nlm.nih.gov/pubmed/28265239
http://dx.doi.org/10.1515/raon-2017-0009
_version_ 1782511210564943872
author Ghorbani, Mahdi
Khajetash, Benyamin
Ghatei, Najmeh
Mehrpouyan, Mohammad
Meigooni, Ali S.
Shahraini, Ramin
author_facet Ghorbani, Mahdi
Khajetash, Benyamin
Ghatei, Najmeh
Mehrpouyan, Mohammad
Meigooni, Ali S.
Shahraini, Ramin
author_sort Ghorbani, Mahdi
collection PubMed
description BACKGROUND: Interstitial rotating shield brachytherapy (I-RSBT) is a recently developed method for treatment of prostate cancer. In the present study TG-43 dosimetric parameters of a (153)Gd source were obtained for use in I-RSBT. MATERIALS AND METHODS: A (153)Gd source located inside a needle including a Pt shield and an aluminum window was simulated using MCNPX Monte Carlo code. Dosimetric parameters of this source model, including air kerma strength, dose rate constant, radial dose function and 2D anisotropy function, with and without the shields were calculated according to the TG-43 report. RESULTS: The air kerma strength was found to be 6.71 U for the non-shielded source with 1 GBq activity. This value was found to be 0.04 U and 6.19 U for the Pt shield and Al window cases, respectively. Dose rate constant for the non-shielded source was found to be 1.20 cGy/(hU). However, for a shielded source with Pt and aluminum window, dose rate constants were found to be 0.07 cGy/(hU) and 0.96 cGy/(hU), on the shielded and window sides, respectively. The values of radial dose function and anisotropy function were tabulated for these sources. Additionally, isodose curves were drawn for sources with and without shield, in order to evaluate the effect of shield on dose distribution. CONCLUSIONS: Existence of the Pt shield may greatly reduce the dose to organs at risk and normal tissues which are located toward the shielded side. The calculated air kerma strength, dose rate constant, radial dose function and 2D anisotropy function data for the (153)Gd source for the non-shielded and the shielded sources can be used in the treatment planning system (TPS).
format Online
Article
Text
id pubmed-5330175
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-53301752017-03-07 Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy Ghorbani, Mahdi Khajetash, Benyamin Ghatei, Najmeh Mehrpouyan, Mohammad Meigooni, Ali S. Shahraini, Ramin Radiol Oncol Research Article BACKGROUND: Interstitial rotating shield brachytherapy (I-RSBT) is a recently developed method for treatment of prostate cancer. In the present study TG-43 dosimetric parameters of a (153)Gd source were obtained for use in I-RSBT. MATERIALS AND METHODS: A (153)Gd source located inside a needle including a Pt shield and an aluminum window was simulated using MCNPX Monte Carlo code. Dosimetric parameters of this source model, including air kerma strength, dose rate constant, radial dose function and 2D anisotropy function, with and without the shields were calculated according to the TG-43 report. RESULTS: The air kerma strength was found to be 6.71 U for the non-shielded source with 1 GBq activity. This value was found to be 0.04 U and 6.19 U for the Pt shield and Al window cases, respectively. Dose rate constant for the non-shielded source was found to be 1.20 cGy/(hU). However, for a shielded source with Pt and aluminum window, dose rate constants were found to be 0.07 cGy/(hU) and 0.96 cGy/(hU), on the shielded and window sides, respectively. The values of radial dose function and anisotropy function were tabulated for these sources. Additionally, isodose curves were drawn for sources with and without shield, in order to evaluate the effect of shield on dose distribution. CONCLUSIONS: Existence of the Pt shield may greatly reduce the dose to organs at risk and normal tissues which are located toward the shielded side. The calculated air kerma strength, dose rate constant, radial dose function and 2D anisotropy function data for the (153)Gd source for the non-shielded and the shielded sources can be used in the treatment planning system (TPS). De Gruyter 2017-02-22 /pmc/articles/PMC5330175/ /pubmed/28265239 http://dx.doi.org/10.1515/raon-2017-0009 Text en © 2017 Radiol Oncol
spellingShingle Research Article
Ghorbani, Mahdi
Khajetash, Benyamin
Ghatei, Najmeh
Mehrpouyan, Mohammad
Meigooni, Ali S.
Shahraini, Ramin
Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy
title Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy
title_full Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy
title_fullStr Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy
title_full_unstemmed Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy
title_short Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy
title_sort determination of dosimetric parameters for shielded (153)gd source in prostate cancer brachytherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330175/
https://www.ncbi.nlm.nih.gov/pubmed/28265239
http://dx.doi.org/10.1515/raon-2017-0009
work_keys_str_mv AT ghorbanimahdi determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy
AT khajetashbenyamin determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy
AT ghateinajmeh determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy
AT mehrpouyanmohammad determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy
AT meigoonialis determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy
AT shahrainiramin determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy